课题基金 / 基金详情

Towards a Universal Influenza Virus Vaccine

Towards a Universal Influenza Virus Vaccine
迈向通用流感病毒疫苗
批准号:
242014
负责人:
Miller Matthew S
金额:
$10.93万
依托单位国家:
加拿大
项目类别:
Fellowship Programs
财政年份:
2011
资助国家:
加拿大
项目状态:
已结题
起止时间:
2011-10-01 至 2014-10-01

项目摘要

项目成果

Miller Matthew S的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Seasonal influenza A virus (IAV) outbreaks represent a significant burden to global healthcare systems. In Canada alone, there were over 39 000 reported cases of IAV during the 2009-2010 season. During the course of a normal season, IAV infections are re
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Unraveling the role of IgA during respiratory virus infections
  • 批准号:
    484190
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2023
  • 负责人:
    Miller Matthew S
  • 依托单位:
Unraveling the role of IgA during respiratory virus infections
  • 批准号:
    489477
  • 项目类别:
    Operating Grants
  • 资助金额:
    $66.6万
  • 财政年份:
    2023
  • 负责人:
    Miller Matthew S
  • 依托单位:
Unravelling the role of IgA during respiratory virus infections
  • 批准号:
    473329
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2022
  • 负责人:
    Miller Matthew S
  • 依托单位:
Canada Research Chair - Tier 2
  • 批准号:
    453974
  • 项目类别:
  • 资助金额:
    $43.71万
  • 财政年份:
    2021
  • 负责人:
    Miller Matthew S
  • 依托单位:
海外基金